Auth bypass in Bd Alaris Cc
CVE-2018-14786
Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.
Vulnerability class: Broken Authentication
Published · last modified .
CVSS v3 metric
CVSS v3 base score 9.4 (Critical). Vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H.
EPSS exploit prediction
EPSS: 0.031 (87.1th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 87th percentile — 87.1% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.031 · newest: 0.031 · change: 0.000
Affected products
Weakness classification (CWE)
References
- www.securityfocus.com/bid/105147 (VDB Entry, Third Party Advisory, vdb-entry)
- www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin… (Vendor Advisory)
- ics-cert.us-cert.gov/advisories/ICSMA-18-235-01 (US Government Resource, Third Party Advisory)
Frequently asked questions
- What is CVE-2018-14786?
- CVE-2018-14786 is a critical-severity vulnerability in Bd Alaris Cc, classified under Improper Authentication. CVSS score: 9.4/10. Published 2018-08-23.
- How severe is CVE-2018-14786?
- Critical severity. CVSS v3 base score is 9.4 out of 10.